A randomized pilot trial using a @-way factorial design allocating patients within @ hours of subarachnoid hemorrhage to either normovolemia ( NV ) or volume expansion ( HV ) and simultaneously to conventional ( CBP ) or augmented blood pressure ( ABP ) for @ days .